Home  »  Market Summary   »  Model N, Inc. (MODN): Latest Results Show Potentia...

Model N, Inc. (MODN): Latest Results Show Potential

Model N, Inc. (NYSE: MODN), a supplier of cloud-based financial management software, has released a good report for the third quarter of the fiscal year 2022. This was the basis for a 28.9% increase in MODN quotations to $33.78 at the auction on August 10th.

Model N’s revenue increased 10% year on year to $56.2 million in the fiscal quarter ending June 30. The net loss was reduced to $6.2 million from $7.8 million the previous year. The per-share loss was $0.17.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.

Sponsored

MODN took another significant stride toward SaaS throughout the quarter. Recurring subscription revenues are up 24%, and this year will be critical in transitioning to a more profitable selling pattern. Subscriptions now account for more than 70% of the company’s entire income.

Model N, Inc. (MODN) includes a comprehensive set of tools for migrating to cloud IT and digitalizing sales, marketing, customer engagement channels, financial management, and legal practice.

MODN will launch Revenue Cloud, a cloud system for automating payments and other business procedures for biotech firms, in the spring of 2022. The Global Price Management software for medical and pharmaceutical firms was also upgraded by Model N. As a result, Model N has significantly updated its flagship suite of solutions in the most promising ways.

Model N, Inc. (MODN) was among the first to provide a solution to assure pricing transparency in such complicated sectors as medicine. Revenue Cloud, in particular, meets American standards for the openness of all financial procedures in the implementation of medical and biotechnological research.

Pfizer, in particular, is using Model N, Inc. (MODN) solutions to manage costs and avoid costly mistakes. In the United States, there are particular regulations governing medication pricing transparency in two dozen states. Failure to meet these criteria might result in severe penalties, hence Model N solutions are in high demand.

MODN had a year-to-date performance of 12.49%. The stock’s price has increased by 28.69% in the last week and 35.17% in the last month, according to the 7-day charts.

Leave a Comment

Your email address will not be published.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]